Post by
Idvhmz123 on Feb 18, 2021 8:33am
HAVN News Release
Havn Life Announces Changes to Board Composition and Departure of Ms. Rasode February 17, 2021, 8:00 am VANCOUVER, BC / ACCESSWIRE / February 17, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), announces the departure of Ms. Barinder Rasode as President and as a director of the Company, effective immediately. The Company also announces that its Chief Executive Officer, Mr. Tim Moore, has been appointed as a director of the Company. Ms. Rasode commented, "We created Havn Life to benefit human health and harness the medicine found in nature. I am so pleased with how far we have come in such a short time. It was always my intention to leave once the right team was in place and the Company well-positioned for success. That time has come, and I leave with confidence and excitement about the Company's future." Mr. Vic Neufeld, Chairman of the Board of Havn Life, commented, "I'd like to thank Barinder for her vision in co-founding the Company and for her contributions toward realizing that vision, and I look forward to her continued support as a shareholder. The Company is extremely fortunate to have in Tim Moore a CEO who has a deep understanding of the biotechnology industry and who has demonstrated time and again the ability to achieve operational milestones while keeping key stakeholders and the wider investment community thoroughly engaged. It's a pleasure to welcome Tim to the Board. We are very excited to strengthen his leadership of the Company and for the future of Havn Life." Mr. Tim Moore commented, "I welcome the opportunity to join the Havn Life Board. We have laid the foundation for continued good governance, with four of five Board members remaining independent of management, and I look forward to adding value in this new capacity as we pursue execution of our business plan." On Behalf of The Board of Directors
Comment by
up2005 on Feb 18, 2021 7:12pm
Is this a concern for the company. As a co-founder of HAVN does the departure of Ms. Barinder Rasode send a negative message. Is she going to start up another related company? Might have timed my entry wrong. Time will tell, so much more research is needed for these psycho-pharmacological drugs. Have to sit tight for 3-4 months and reevaluate.